Product NDC: | 44183-514 |
Proprietary Name: | V-COF |
Non Proprietary Name: | brompheniramine maleate, PHENYLEPHRINE HYDROCHLORIDE, and CARBETAPENTANE CITRATE |
Active Ingredient(s): | 6; 25; 10 mg/5mL; mg/5mL; mg/5mL & nbsp; brompheniramine maleate, PHENYLEPHRINE HYDROCHLORIDE, and CARBETAPENTANE CITRATE |
Administration Route(s): | ORAL |
Dosage Form(s): | SUSPENSION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 44183-514 |
Labeler Name: | Macoven Pharmaceuticals |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | |
Marketing Category: | UNAPPROVED DRUG OTHER |
Start Marketing Date: | 20100204 |
Package NDC: | 44183-514-04 |
Package Description: | 118 mL in 1 BOTTLE (44183-514-04) |
NDC Code | 44183-514-04 |
Proprietary Name | V-COF |
Package Description | 118 mL in 1 BOTTLE (44183-514-04) |
Product NDC | 44183-514 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | brompheniramine maleate, PHENYLEPHRINE HYDROCHLORIDE, and CARBETAPENTANE CITRATE |
Dosage Form Name | SUSPENSION |
Route Name | ORAL |
Start Marketing Date | 20100204 |
Marketing Category Name | UNAPPROVED DRUG OTHER |
Labeler Name | Macoven Pharmaceuticals |
Substance Name | BROMPHENIRAMINE MALEATE; CARBETAPENTANE CITRATE; PHENYLEPHRINE HYDROCHLORIDE |
Strength Number | 6; 25; 10 |
Strength Unit | mg/5mL; mg/5mL; mg/5mL |
Pharmaceutical Classes |